<DOC>
	<DOCNO>NCT00598533</DOCNO>
	<brief_summary>The purpose trial evaluate efficacy Rapamycin- Zotarolimus-Eluting stent reduction Coronary Restenosis</brief_summary>
	<brief_title>Efficacy Study Rapamycin- vs. Zotarolimus-Eluting Stents Reduce Coronary Restenosis</brief_title>
	<detailed_description>This prospective , randomized trial compare efficacy safety Rapamycin plus Probucol-eluting stent polymer base Zotarolimus-eluting stent . Patients symptomatic coronary artery disease without cardiogenic shock undergo coronary angiography willing participate trial receive load dose 600mg clopidogrel least 2 hour procedure . They randomize receive one mention stent .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Probucol</mesh_term>
	<criteria>Patients old age 18 ischemic symptom evidence myocardial ischemia presence â‰¥ 50 % de novo stenosis locate native coronary vessel Written , inform consent patient her/his legallyauthorized representative participation study In woman childbearing potential negative pregnancy test mandatory . Target lesion locate leave main trunk . Target lesion locate bypass graft . Instent restenosis . Cardiogenic shock . Malignancies comorbid condition ( example severe liver , renal pancreatic disease ) life expectancy le 12 month may result protocol noncompliance . Known allergy study medication : Clopidogrel , Rapamycin , Probucol , Zotarolimus , stainless steel cobalt chrome . Inability take clopidogrel least 6 month . Pregnancy ( present , suspected plan ) positive pregnancy test . Previous enrollment trial . Patient 's inability fully cooperate study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>